Literature DB >> 19553376

Health-related quality of life, employment and disability in patients with Sjogren's syndrome.

Jiska M Meijer1, Petra M Meiners, James J R Huddleston Slater, Fred K L Spijkervet, Cees G M Kallenberg, Arjan Vissink, Hendrika Bootsma.   

Abstract

OBJECTIVE: To compare health-related quality of life (HR-QOL), employment and disability of primary and secondary SS (pSS and sSS, respectively) patients with the general Dutch population.
METHODS: HR-QOL, employment and disability were assessed in SS patients regularly attending the University Medical Center Groningen (n = 235). HR-QOL, employment and disability were evaluated with the Short Form-36 questionnaire (SF-36) and an employment and disability questionnaire. Results were compared with Dutch population data (matched for sex and age). Demographical and clinical data associated with HR-QOL, employment and disability were assessed.
RESULTS: Response rate was 83%. SS patients scored lower on HR-QOL than the general Dutch population. sSS patients scored lower on physical functioning, bodily pain and general health than pSS patients. Predictors for reduced HR-QOL were fatigue, tendomyalgia, articular involvement, use of artificial saliva, use of anti-depressants, comorbidity, male sex and eligibility for disability compensation (DC). Employment was lower and DC rates were higher in SS patients compared with the Dutch population.
CONCLUSION: SS has a large impact on HR-QOL, employment and disability.

Entities:  

Mesh:

Year:  2009        PMID: 19553376     DOI: 10.1093/rheumatology/kep141

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  59 in total

1.  A possible genetic association with chronic fatigue in primary Sjögren's syndrome: a candidate gene study.

Authors:  Katrine Brække Norheim; Stephanie Le Hellard; Gunnel Nordmark; Erna Harboe; Lasse Gøransson; Johan G Brun; Marie Wahren-Herlenius; Roland Jonsson; Roald Omdal
Journal:  Rheumatol Int       Date:  2013-09-03       Impact factor: 2.631

Review 2.  Productivity Losses and Costs in the Less-Common Systemic Autoimmune Rheumatic Diseases.

Authors:  Natalie McCormick; Carlo A Marra; J Antonio Aviña-Zubieta
Journal:  Curr Rheumatol Rep       Date:  2017-10-30       Impact factor: 4.592

3.  [Sialadenitis and sialolithiasis].

Authors:  H Maier
Journal:  HNO       Date:  2010-03       Impact factor: 1.284

Review 4.  The value of animal models to study immunopathology of primary human Sjögren's syndrome symptoms.

Authors:  Amy Donate; Alexandria Voigt; Cuong Q Nguyen
Journal:  Expert Rev Clin Immunol       Date:  2014-02-10       Impact factor: 4.473

5.  Illness perceptions and psychological distress associated with physical health-related quality of life in primary Sjögren's syndrome compared to systemic lupus erythematosus and rheumatoid arthritis.

Authors:  Konstantinos Kotsis; Paraskevi V Voulgari; Niki Tsifetaki; Alexandros A Drosos; André F Carvalho; Thomas Hyphantis
Journal:  Rheumatol Int       Date:  2014-04-27       Impact factor: 2.631

6.  Decrease in alpha-1 antiproteinase antitrypsin is observed in primary Sjogren's syndrome condition.

Authors:  Brij B Singh; Joyce Ohm; Fredice O Quenum Zanbede; Pooja Chauhan; Frans G M Kroese; Arjan Vissink; Julian L Ambrus; Bibhuti B Mishra
Journal:  Autoimmunity       Date:  2020-05-25       Impact factor: 2.815

7.  Patient reported outcome and experience measures of oral disease in oral medicine.

Authors:  R Ní Ríordáin; P Wiriyakijja
Journal:  Br Dent J       Date:  2017-11-03       Impact factor: 1.626

8.  Supervised walking improves cardiorespiratory fitness, exercise tolerance, and fatigue in women with primary Sjögren's syndrome: a randomized-controlled trial.

Authors:  Samira Tatiyama Miyamoto; Valéria Valim; Luciana Carletti; Wan-Fai Ng; Anselmo José Perez; Dennis William Lendrem; Michael Trennel; Raquel Altoé Giovelli; Laiza Hombre Dias; Érica Vieira Serrano; Alice Mendonça Subtil; Vanessa Cândido Abreu; Jamil Natour
Journal:  Rheumatol Int       Date:  2019-01-02       Impact factor: 2.631

Review 9.  Current and future therapies for primary Sjögren syndrome.

Authors:  Raphaèle Seror; Gaetane Nocturne; Xavier Mariette
Journal:  Nat Rev Rheumatol       Date:  2021-06-29       Impact factor: 20.543

Review 10.  Sjögren's syndrome in older patients: aetiology, diagnosis and management.

Authors:  Rada V Moerman; Hendrika Bootsma; Frans G M Kroese; Arjan Vissink
Journal:  Drugs Aging       Date:  2013-03       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.